What is Daniel J Wallace, MD?
Operating as a specialized medical foundation, Daniel J Wallace, MD, focuses on the comprehensive management and treatment of autoimmune rheumatic conditions, including lupus and rheumatoid arthritis. The organization distinguishes itself through a unique integration with the Cedars-Sinai Medical Center, where leadership plays a pivotal role in the Rheumatology Fellowship Program. Unlike traditional corporate-backed entities, the foundation maintains an independent structure, ensuring that all philanthropic contributions are directed toward patient assistance, clinical research, and the development of innovative therapeutic protocols. This model allows for a highly targeted approach to medical care, where decades of clinical expertise guide the allocation of resources to the most pressing areas of rheumatic disease management.
How much funding has Daniel J Wallace, MD raised?
Daniel J Wallace, MD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Daniel J Wallace, MD
PPP
Public-Private Partnership
What's next for Daniel J Wallace, MD?
With this latest infusion of capital, the foundation is well-positioned to scale its research initiatives and expand access to medical grants for patients in need. The strategic roadmap involves deepening the synergy between clinical practice and academic research, potentially accelerating the discovery of new treatment modalities for chronic autoimmune disorders. As the foundation continues to operate independently of large corporate interests, the focus will remain on maintaining high-impact, direct-to-patient support systems. Future growth will likely center on enhancing the reach of the Rheumatology Fellowship Program and fostering collaborative efforts that bridge the gap between laboratory research and bedside application, ultimately improving long-term outcomes for patients suffering from complex rheumatic conditions.
See full Daniel J Wallace, MD company page
